Insiders · AKYA

AKYA insider transactions

Akoya BioSciences Inc. (AKYA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

AKYA insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Akoya BioSciences Inc., latest first. Follow anyone to get their next filing.

• Scott MendelDirector, since June 2021+$212K
• Niro Ph.D RamachandranChief Business Officer, since April 2021+$329K
• Brian McKelligonPresident and CEO, Director, since April 2021-$458K
• Jennifer KamocsayChief Legal Officer, since February 2023
• John Frederick EkCFO, since March 2023+$100K
• Pascal BamfordChief Clinical Officer, since August 2024
• Matthew WinklerDirector, since April 2021+$1.02M
• Robert G SheplerDirector, since April 2021+$1.04M
• Thomas P SchnettlerDirector, since April 2021-$926K
• Thomas A. RaffinDirector, since April 2021+$10.1M
• Goldman Myla LaiDirector, since September 2021+$100K
• Frederic PlaChief Operating Officer, since April 2021+$92K
• Garry Ph.D. NolanDirector, since April 2021-$1.16M
• Ehab El-GabryOfficer, since April 2022
• Joseph DriscollOfficer, since April 2021-$309K
• Marilee MoyOfficer, since January 2022

Recent Form 3, 4, and 5 filings for AKYA

• 486d
  Director Mendel Scott disposed of 28,500 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  Chief Business Officer Ramachandran Niro Ph.D acquired 62,566 shares, covered exercise/tax liability with 42,148 shares and disposed of 282,555 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  President and CEO Mckelligon Brian disposed of 947,688 shares, acquired 724,428 shares and covered exercise/tax liability with 196,866 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  Chief Legal Officer Kamocsay Jennifer disposed of 179,272 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  CFO Ek John Frederick disposed of 268,202 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  Chief Clinical Officer Bamford Pascal disposed of 205,738 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  Director Winkler Matthew disposed of 984,513 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  SEC Form 4 filed by Director Shepler Robert G

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  SEC Form 4 filed by Director Schnettler Thomas P

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  Director Raffin Thomas A. disposed of 17,909,839 shares (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 486d
  Director Lai Goldman Myla disposed of 20,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 525d
  Chief Clinical Officer Bamford Pascal covered exercise/tax liability with 670 shares, decreasing direct ownership by 0.32% to 205,738 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 585d
  CFO Ek John Frederick covered exercise/tax liability with 16,432 shares, decreasing direct ownership by 6% to 248,202 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 593d
  President and CEO Mckelligon Brian covered exercise/tax liability with 7,550 shares, decreasing direct ownership by 2% to 420,126 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 593d
  Chief Business Officer Ramachandran Niro Ph.D covered exercise/tax liability with 2,310 shares, decreasing direct ownership by 0.80% to 287,210 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 615d
  Chief Legal Officer Kamocsay Jennifer covered exercise/tax liability with 7,445 shares, decreasing direct ownership by 4% to 179,272 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 615d
  CFO Ek John Frederick covered exercise/tax liability with 3,594 shares, decreasing direct ownership by 1% to 264,634 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 615d
  Chief Clinical Officer Bamford Pascal covered exercise/tax liability with 3,850 shares, decreasing direct ownership by 2% to 206,408 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 615d
  Chief Business Officer Ramachandran Niro Ph.D covered exercise/tax liability with 5,904 shares, decreasing direct ownership by 2% to 289,520 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 615d
  President and CEO Mckelligon Brian covered exercise/tax liability with 15,807 shares, decreasing direct ownership by 4% to 427,676 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 718d
  Chief Legal Officer Kamocsay Jennifer was granted 87,500 shares, increasing direct ownership by 88% to 186,717 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 718d
  CFO Ek John Frederick was granted 87,500 shares, increasing direct ownership by 48% to 268,228 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 718d
  Chief Clinical Officer Bamford Pascal was granted 87,500 shares, increasing direct ownership by 71% to 210,258 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 718d
  Chief Business Officer Ramachandran Niro Ph.D was granted 87,500 shares, increasing direct ownership by 42% to 295,424 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 718d
  President and CEO Mckelligon Brian was granted 218,750 shares, increasing direct ownership by 97% to 443,483 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 765d
  SEC Form 4 filed by Director Mendel Scott

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 796d
  Chief Clinical Officer Bamford Pascal was granted 40,000 shares, increasing direct ownership by 48% to 122,758 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 796d
  New insider Bamford Pascal claimed ownership of 82,758 shares (SEC Form 3)

  3 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 880d
  President and CEO Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $15,630 worth of shares (7,500 units at $2.08) (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 884d
  Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $15,064 worth of shares (7,500 units at $2.01) (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 887d
  SEC Form 4 filed by Raffin Thomas A.

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 887d
  SEC Form 4 filed by Shepler Robert G

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 887d
  SEC Form 4 filed by Winkler Matthew

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 887d
  SEC Form 4 filed by Schnettler Thomas P

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 887d
  SEC Form 4 filed by Lai Goldman Myla

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 887d
  SEC Form 4 filed by Mendel Scott

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 951d
  Ek John Frederick covered exercise/tax liability with 14,272 shares, decreasing direct ownership by 7% to 180,728 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 959d
  Pla Frederic covered exercise/tax liability with 2,006 shares, decreasing direct ownership by 2% to 101,500 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 959d
  Ramachandran Niro Ph.D covered exercise/tax liability with 2,006 shares, decreasing direct ownership by 0.96% to 207,924 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 959d
  Mckelligon Brian covered exercise/tax liability with 7,135 shares, decreasing direct ownership by 3% to 224,733 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 962d
  Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $37,243 worth of shares (7,500 units at $4.97) (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 962d
  Mckelligon Brian sold $37,042 worth of shares (7,500 units at $4.94) and exercised 7,500 shares at a strike of $0.30 (SEC Form 4) (Amendment)

  4/A - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 969d
  Mckelligon Brian sold $37,035 worth of shares (7,500 units at $4.94), decreasing direct ownership by 3% to 224,368 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 969d
  Shepler Robert G gifted 369,592 shares and received a gift of 369,592 shares (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 980d
  Mckelligon Brian was granted 87,500 shares and covered exercise/tax liability with 8,195 shares, increasing direct ownership by 52% to 231,868 units (SEC Form 4) (Amendment)

  4/A - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 982d
  Ek John Frederick was granted 35,000 shares, increasing direct ownership by 22% to 195,000 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 982d
  Kamocsay Jennifer was granted 35,000 shares and covered exercise/tax liability with 3,283 shares, increasing direct ownership by 47% to 99,217 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 982d
  Ramachandran Niro Ph.D was granted 35,000 shares and covered exercise/tax liability with 2,305 shares, increasing direct ownership by 18% to 209,930 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 982d
  Pla Frederic was granted 35,000 shares and covered exercise/tax liability with 2,049 shares, increasing direct ownership by 47% to 103,506 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 982d
  Mckelligon Brian was granted 87,500 shares and covered exercise/tax liability with 10,244 shares, decreasing direct ownership by 32% to 103,506 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1054d
  Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $33,566 worth of shares (7,500 units at $4.48) (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1061d
  Mckelligon Brian exercised 7,500 shares at a strike of $0.30 and sold $31,871 worth of shares (7,500 units at $4.25) (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1077d
  Pla Frederic was granted 30,000 shares, increasing direct ownership by 74% to 70,555 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1077d
  Kamocsay Jennifer was granted 30,000 shares, increasing direct ownership by 80% to 67,500 units (SEC Form 4)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1155d
  SEC Form 4: Pla Frederic bought $92,014 worth of shares (20,000 units at $4.60)

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1246d
  SEC Form 4 filed by Ek John Frederick

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1246d
  SEC Form 4 filed by Lai Goldman Myla

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1246d
  SEC Form 4 filed by Mendel Scott

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1246d
  SEC Form 4 filed by Winkler Matthew

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
• 1246d
  SEC Form 4 filed by Shepler Robert G

  4 - Akoya Biosciences, Inc. (0001711933) (Issuer)